Susquehanna International Group’s NextCure NXTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,459
Closed -$13.6K 13456
2025
Q2
$13.6K Buy
+2,459
New +$13.2K ﹤0.01% 12379
2025
Q1
Sell
-4,016
Closed -$37.2K 13160
2024
Q4
$37.2K Buy
+4,016
New +$59.1K ﹤0.01% 11785
2023
Q4
Sell
-1,091
Closed -$16.9K 13014
2023
Q3
$16.9K Sell
1,091
-2,182
-67% -$41.6K ﹤0.01% 11640
2023
Q2
$70.7K Buy
3,273
+922
+39% +$18.2K ﹤0.01% 11176
2023
Q1
$41.8K Sell
2,351
-1,645
-41% -$31.7K ﹤0.01% 11765
2022
Q4
$67.6K Buy
+3,996
New +$91.9K ﹤0.01% 11231
2022
Q2
Sell
-9,251
Closed -$483K 13621
2022
Q1
$540K Buy
9,251
+1,725
+23% +$108K ﹤0.01% 8780
2021
Q4
$542K Buy
7,526
+2,534
+51% +$212K ﹤0.01% 8968
2021
Q3
$404K Buy
+4,992
New +$438K ﹤0.01% 9918
2020
Q3
Sell
-1,930
Closed -$237K 10962
2020
Q2
$497K Buy
1,930
+1,170
+154% +$445K ﹤0.01% 7377
2020
Q1
$338K Buy
760
+113
+17% +$60.4K ﹤0.01% 7744
2019
Q4
$437K Buy
+647
New +$325K ﹤0.01% 7254

Other funds holding NXTC

Susquehanna International Group's NXTC Position: Q3 2025 in Review

Susquehanna International Group sold out of NextCure (NXTC) in Q3 2025, closing a stake of 2,459 shares — an estimated $13.6K sold.

Susquehanna International Group first reported a position in NXTC in Q4 2019 and held it in 12 quarters. The position peaked at $542K in Q4 2021. 17 funds tracked by Wall St. Rank hold NXTC as of Q3 2025.

  • Susquehanna International Group reported no remaining NextCure position as of Q3 2025 after selling out during the quarter.
  • Susquehanna International Group sold 2,459 NextCure shares in Q3 2025, an estimated $13.6K.
  • Susquehanna International Group first reported a position in NextCure in Q4 2019 and held it in 12 quarters.
  • Susquehanna International Group's NextCure position peaked at $542K in Q4 2021.
  • 17 funds tracked by Wall St. Rank held NextCure as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.